HISTAMINE INHIBITION OF NEUTROPHIL LYSOSOMAL ENZYME RELEASE: AN H2 HISTAMINE RECEPTOR RESPONSE.BUSSE WW; SOSMAN J.1976; SCIENCE; U.S.A.; DA. 1976; VOL. 194; NO 4266; PP. 737-738; BIBL. 21 REF.Article

DECREASED H2 HISTAMINE RESPONSE OF GRANULOCYTES OF ASTHMATIC PATIENTS.BUSSE WW; SOSMAN J.1977; J. CLIN. INVEST.; U.S.A.; DA. 1977; VOL. 59; NO 6; PP. 1080-1087; BIBL. 37 REF.Article

Flavopiridol, a novel cyclin-dependent kinase inhibitor, in metastatic renal cancer: A university of chicago phase II consortium studySTADLER, W. M; VOGELZANG, N. J; AMATO, R et al.Journal of clinical oncology. 2000, Vol 18, Num 2, pp 371-375, issn 0732-183XArticle

Temozolomide and whole brain irradiation in melanoma metastatic to the brain: a phase II trial of the Cytokine Working GroupMARGOLIN, K; ATKINS, M. B; DUTCHER, J. P et al.Journal of cancer research and clinical oncology. 2002, Vol 128, Num 4, pp 214-218, issn 0171-5216Article

Outpatient biochemotherapy with interleukin-2 and interferon alfa-2b in patients with metastatic malignant melanoma: results of two phase II Cytokine Working Group trialsFLAHERTY, L. E; ATKINS, M; SOROKIN, P et al.Journal of clinical oncology. 2001, Vol 19, Num 13, pp 3194-3202, issn 0732-183XArticle

Safety and outcome after fludarabine-thiotepa-TBI conditioning for allogeneic transplantation: a prospective study of 30 patients with hematologic malignanciesVAN BESIEN, K; DEVINE, S; CHEN, Y-H et al.Bone marrow transplantation (Basingstoke). 2003, Vol 32, Num 1, pp 9-13, issn 0268-3369, 5 p.Article

A phase II trial of interleukin-2 in myelodysplastic syndromesNAND, S; STOCK, W; STIFF, P et al.British journal of haematology. 1998, Vol 101, Num 1, pp 205-207, issn 0007-1048Article

Clinical and immunological effects of treatment with murine anti-CD3 monoclonal antibody along with interleukin 2 in patients with cancerHANK, J. A; ALBERTINI, M; SOSMAN, J et al.Clinical cancer research. 1995, Vol 1, Num 5, pp 481-491, issn 1078-0432Article

Multi-institutional study of the angiogenesis inhibitor TNP-470 in metastatic renal carcinomaSTADLER, W. M; KUZEL, T; SHAPIRO, C et al.Journal of clinical oncology. 1999, Vol 17, Num 8, pp 2541-2545, issn 0732-183XArticle

Prospective randomized trial of lisofylline for the prevention of toxicities of high-dose interleukin 2 therapy in advanced renal cancer and malignant melanomaMARGOLIN, K; ATKINS, M; CAMPBELL, E et al.Clinical cancer research. 1997, Vol 3, Num 4, pp 565-572, issn 1078-0432Article

A phase I/II study of sequential interleukin-3 and granulocyte-macrophage colony-stimulating factor in myelodysplastic syndromesNAND, S; SOSMAN, J; GODWIN, J. E et al.Blood. 1994, Vol 83, Num 2, pp 357-360, issn 0006-4971Article

Phase II studies of bryostatin-1 in patients with advanced sarcoma and advanced head and neck cancerBROCKSTEIN, B; SAMUELS, B; HUMERICKHOUSE, R et al.Investigational new drugs. 2001, Vol 19, Num 3, pp 249-254, issn 0167-6997Article

Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell diseaseVAN BESIEN, K; BARTHOLOMEW, A; STOCK, W et al.Bone marrow transplantation (Basingstoke). 2000, Vol 26, Num 4, pp 445-449, issn 0268-3369Article

A phase II trial of high-dose mitoxantrone, carboplatin and cyclophosphamide with autologous bone marrow rescue for recurrent epithelial ovarian carcinoma : analysis of risk factors for clinical outcomeSTIFF, P; BAYER, R; RAD, N et al.Gynecologic oncology (Print). 1995, Vol 57, Num 3, pp 278-285, issn 0090-8258Article

High-dose chemotherapy combined with escalating doses of cyclosporin A and an autologous bone marrow transplant for the treatment of drug-resistant solid tumors : a phase I clinical trialSTIFF, P. J; BAYER, R; TAN, S et al.Clinical cancer research. 1995, Vol 1, Num 12, pp 1495-1502, issn 1078-0432Article

Severe eosinophilia and hepatocellular carcinoma: an unusual associationYUEN, B. H; REYES, C. V; RAWAL, P. A et al.Diagnostic cytopathology. 1995, Vol 13, Num 2, pp 151-154, issn 8755-1039Article

The graft-vs.-leukemia effect : implications for post-marrow transplant antileukemia treatment : Bone marrow transplantationSOSMAN, J. A; SONDEL, P. M.The American journal of pediatric hematology/oncology. 1993, Vol 15, Num 2, pp 185-195, issn 0192-8562Article

Isoproterenol inhibition of isolated human neutrophil functionBUSSE, W. W; SOSMAN, J. M.Journal of allergy and clinical immunology. 1984, Vol 73, Num 3, pp 404-410, issn 0091-6749Article

FUNCTIONAL ANALYSIS OF HUMAN T CELL SUBSETS DEFINED BY MONOCLONAL ANTIBODIES. III: REGULATION OF HELPER FACTOR PRODUCTION BY T CELL SUBSETSTHOMAS Y; SOSMAN J; ROGOZINSKI L et al.1981; J. IMMUNOL.; ISSN 0022-1767; USA; DA. 1981; VOL. 126; NO 5; PP. 1948-1951; BIBL. 18 REF.Article

FUNCTIONAL ANALYSIS OF HUMAN T CELL SUBSETS DEFINED BY MONOCLONAL ANTIBODIES. I: COLLABORATIVE T-T INTERACTIONS IN THE IMMUNOREGULATION OF B CELL DIFFERENTIATIONTHOMAS Y; SOSMAN J; IRIGOYEN O et al.1980; J. IMMUNOL.; ISSN 0022-1767; USA; DA. 1980; VOL. 125; NO 6; PP. 2402-2408; BIBL. 34 REF.Article

ENHANCEMENT OF T CELL CYTOTOXIC RESPONSES BY PURIFIED HUMAN FIBROBLAST INTERFERONZARLING JM; SOSMAN J; ESKRA L et al.1978; J. IMMUNOL.; USA; DA. 1978; VOL. 121; NO 5; PP. 2002-2004; BIBL. 21 REF.Article

Symptomatic intravertebral disc herniation (Schmorl's node) in the cervical spineLIPSON, S. J; FOX, D. A; SOSMAN, J. L et al.Annals of the rheumatic diseases. 1985, Vol 44, Num 12, pp 857-859, issn 0003-4967Article

A phase I trial of continuous infusion interleukin-4 (IL-4) alone and following interleukin-2 (IL-2) in cancer patientsSOSMAN, J. A; FISHER, S. G; KEFER, C et al.Annals of oncology. 1994, Vol 5, Num 5, pp 447-452, issn 0923-7534Article

Specific recognition of human leukemic cells by allogeneic T cell linesSOSMAN, J. A; OETTEL, K. R; HANK, J. A et al.Transplantation. 1989, Vol 48, Num 3, pp 486-495, issn 0041-1337, 10 p.Article

Induction of human cytotoxic T lymphocytes specific for prostate-specific antigenXUE, B.-H; ZHANG, Y; SOSMAN, J. A et al.The Prostate. 1997, Vol 30, Num 2, pp 73-78, issn 0270-4137Article